Challenges in Brain Death Determination and Apnea Testing for Patients with COVID-19.
J Stroke Cerebrovasc Dis
; 29(12): 105419, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-885361
ABSTRACT
INTRODUCTION:
Apnea testing remains essential for the clinical evaluation of brain death determination. In patients who test positive for SARS-CoV-2, disconnecting the patient from the ventilator and introducing high flow oxygen into the endotracheal tube increases the risk for aerosolization of airway secretions and exposure of the examiner.METHODS:
Case report of a patient with an intracerebral hemorrhage that evolved to significant cerebral edema and herniation, who underwent apnea test using a method involving a t-piece and an HME filter.RESULTS:
Patient successfully pronounced brain dead using a safe method to minimize exposure to SARS-CoV-2.CONCLUSION:
At a time where healthcare workers are at high risk of exposure to COVID-19, the above described method is a safe process for apnea testing in declaration of brain death.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Apnea
/
Brain Death
/
Brain Edema
/
Cerebral Hemorrhage
/
Occupational Health
/
Infectious Disease Transmission, Patient-to-Professional
/
Encephalocele
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
J Stroke Cerebrovasc Dis
Journal subject:
Vascular Diseases
/
Brain
Year:
2020
Document Type:
Article
Affiliation country:
J.jstrokecerebrovasdis.2020.105419
Similar
MEDLINE
...
LILACS
LIS